154 related articles for article (PubMed ID: 9652298)
1. HMOs and ESRD: a gloomy scenario.
Steinman TI
Nephrol News Issues; 1998 May; 12(5 Suppl):30, 33. PubMed ID: 9652298
[No Abstract] [Full Text] [Related]
2. ESRD modality selection into the 21st century: the importance of non medical factors.
Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
[No Abstract] [Full Text] [Related]
3. Dialysis care in 1999: reality and challenges.
Bosch JP; Bander S
J Nephrol; 2000; 13 Suppl 3():S7-9. PubMed ID: 11132036
[No Abstract] [Full Text] [Related]
4. ESRD demonstration aligns incentives.
Neumann ME
Nephrol News Issues; 2011 Feb; 25(2):8. PubMed ID: 21466017
[No Abstract] [Full Text] [Related]
5. HMOs and ESRD: can it work?
Hannah RG
Nephrol News Issues; 1998 Aug; 12(8):48, 50-1. PubMed ID: 9923288
[TBL] [Abstract][Full Text] [Related]
6. Conditions for coverage fail to relieve administrative burden.
Wish D
Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
[No Abstract] [Full Text] [Related]
7. [Kidney dialysis and transplantation].
Makó J
Orv Hetil; 2000 Dec; 141(50):2749. PubMed ID: 11189682
[No Abstract] [Full Text] [Related]
8. Evaluation of the ESRD managed care demonstration operations.
Oppenheimer CC; Shapiro JR; Beronja N; Dykstra DM; Gaylin DS; Held PJ; Rubin RJ
Health Care Financ Rev; 2003; 24(4):7-29. PubMed ID: 14628397
[TBL] [Abstract][Full Text] [Related]
9. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration.
Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874
[No Abstract] [Full Text] [Related]
10. Establishing and controlling chronic renal failure treatment costs. A pressing need.
Martín Hernández R
Nefrologia; 2011; 31(3):256-9. PubMed ID: 21629334
[No Abstract] [Full Text] [Related]
11. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
Manns B; Meltzer D; Taub K; Donaldson C
Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
[TBL] [Abstract][Full Text] [Related]
12. Maintenance dialysis population dynamics: current trends and long-term implications.
Lysaght MJ
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S37-40. PubMed ID: 11792760
[TBL] [Abstract][Full Text] [Related]
13. Cost functions for dialysis facilities and the quality of dialysis.
Escarce JJ; Feldman HI
Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497
[No Abstract] [Full Text] [Related]
14. Evidence missing to support moving ESRD patients into HMOs.
Charytan C
Nephrol News Issues; 2000 Jul; 14(8):13-4. PubMed ID: 12101515
[No Abstract] [Full Text] [Related]
15. Technical and economic strategies of maintenance dialysis in the UK and Nordic Countries.
Cantaluppi A; East P
J Nephrol; 2000; 13 Suppl 3():S10-5. PubMed ID: 11132025
[TBL] [Abstract][Full Text] [Related]
16. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
Prodjosudjadi W
Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
[TBL] [Abstract][Full Text] [Related]
17. Caring for ESRD patients.
Andriote JM
Healthplan; 1998; 39(4):33-5. PubMed ID: 10351321
[No Abstract] [Full Text] [Related]
18. End stage renal disease--the end of the road.
Rao M
Natl Med J India; 1992; 5(5):241-3. PubMed ID: 1302587
[No Abstract] [Full Text] [Related]
19. The first ESRD managed care demonstration project: a Kaiser Permanente view.
Crooks P
Nephrol News Issues; 2003 Oct; 17(11):29-31, 34-5. PubMed ID: 14593817
[No Abstract] [Full Text] [Related]
20. ESRD program at the crossroads of health care reform.
Neumann ME
Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
